Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of
semiconductor test and reliability qualification equipment, today
announced financial results for its second quarter of fiscal 2021
ended November 30, 2020.
Fiscal Second Quarter Financial Results:
- Net sales were $1.7 million, compared to $6.9 million in the
second quarter of fiscal 2020.
- GAAP net loss was $2.0 million, or $0.08 per diluted share,
compared to GAAP net income of $251,000, or $0.01 per diluted
share, in the second quarter of fiscal 2020.
- Non-GAAP net loss was $1.7 million, or $0.07 per diluted share,
which excludes the impact of stock-based compensation, compared to
non-GAAP net income of $456,000, or $0.02 per diluted share, in the
second quarter of fiscal 2020.
- Backlog as of November 30, 2020 was $1.1 million.
Fiscal First Six Months Financial Results:
- Net sales were $3.7 million, compared to $12.4 million in the
first six months of fiscal 2020.
- GAAP net loss was $1.9 million, or $0.08 per diluted share,
compared to a GAAP net loss of $162,000, or $0.01 per diluted
share, in the first six months of fiscal 2020.
- Non-GAAP net loss was $3.7 million, or $0.16 per diluted share,
which excludes the impact of stock-based compensation and non-cash
net gain of $2.2 million and a tax benefit of $215,000 related
to the closure of Aehr’s Japan subsidiary during the first quarter.
This compared to non-GAAP net income of $242,000, or $0.01 per
diluted share, in the first six months of fiscal 2020.
An explanation of the use of non-GAAP financial measures and a
reconciliation of Aehr’s non-GAAP financial measures to the most
directly comparable GAAP financial measures can be found in the
accompanying tables.
Fiscal First Six Months COVID-19 Related Business
Impacts:
- Bookings and Revenue Negatively Impacted by COVID-19
– Bookings and revenues during the first six months of
fiscal 2021 were negatively impacted due to several
customer-specific production ramp delays and push outs due to
COVID-19 related impacts. Aehr continues to be optimistic about
generating significant bookings and revenue increases in the second
half of the 2021 fiscal year compared to the first half.
- New Customer Evaluations and Orders Experienced Delays
– While Aehr continues to engage in ongoing discussions
with a large number of potential new customers, these discussions
have been slowed by travel-related restrictions due to the COVID-19
pandemic and related precautions taken by several new potential
customers worldwide, including policies for limited on-site
engineers, which have delayed evaluations and initial orders for
Aehr’s systems and consumable products in the first six months of
fiscal 2021.
- Temporary Cost Reductions Implemented in Response to
Delays in Expected Orders and Revenue – During the first
quarter of fiscal 2021, Aehr implemented temporary expense
reductions across Aehr including executive staff pay reductions due
to customer order push outs and delays in production ramps. These
changes resulted in total cost savings of over $550,000 in the
second quarter of fiscal 2021.
Fiscal Second Quarter and Recent Business
Highlights:
- Received $4.3 million initial order from a new customer that is
a supplier of sensors to a major mobile device manufacturer for a
FOX-XP™ production test and burn-in system, a set of DiePak
Carriers®, and a FOX Automated DiePak loader / unloader for a new
high-volume application for production test and burn-in of mobile
sensors. Aehr was selected due to the unique technical capabilities
and cost effectiveness of its solution critical to this
application, which will require 100% test, burn-in, traceability
and validation of the devices.
- Received a design win and an initial order for multiple DiePak
Carriers for test and burn-in of next generation sensor modules for
mobile devices, expanding deployment of its test solutions to
additional devices with this large multinational customer. The
customer will use these Aehr proprietary DiePaks for production
qualification, test, and burn-in of these devices prior to volume
production orders for additional DiePaks forecasted for later in
Aehr’s current fiscal year.
- Since the beginning of fiscal third quarter, Aehr has received
multiple follow-on orders and is seeing an increase in bookings
forecasts for its proprietary WaferPakTM and DiePak consumables
across multiple market segments including silicon photonics,
silicon carbide, mobile sensors, and flash memory for Aehr’s
installed base of FOX multi-wafer and singulated die/module test
systems. These orders reflect capacity and consumable needs for
previously announced new design wins as well as recent new design
wins from customers for devices in these key market segments.
Gayn Erickson, President and CEO of Aehr Test
Systems, commented:
“As we anticipated last quarter, our revenue and bookings for
the first half of our fiscal year were impacted by the continued
challenging global business environment created by the COVID-19
pandemic and several customer specific production ramp delays and
push outs of forecasted orders. These customers continue to
indicate they believe the push outs are temporary and that they
will require additional system capacity and consumables this fiscal
year, and we continue to be optimistic about the second half of the
year for significant bookings and revenue increases over the first
half.
“At the start of the third quarter, we were excited to receive a
new design win for a new high-volume application for production
test and burn-in of mobile sensors, which began with an initial
$4.3 million order from this new customer that is a supplier of
sensors to a major mobile device manufacturer. This initial test
cell is expected to ship during the current fiscal third quarter
and we expect follow-on capacity orders from this customer later in
the current fiscal year for additional test system capacity, DiePak
Carriers and our DiePak auto loader solution for handling.
“Since the beginning of this fiscal third quarter, we have also
seen an increase in bookings and forecasts for additional WaferPaks
and DiePaks consumables for our installed base of systems,
reflecting customer capacity and consumable needs for our
previously announced new design wins. We are forecasting additional
DiePaks and WaferPaks orders during the second half of the 2021
fiscal year from our installed base for applications in silicon
photonics, silicon carbide, mobile sensors, and flash memory market
segments.
“As we’ve noted before, Aehr’s proprietary test and burn-in
solutions include customized WaferPaks and DiePaks that are needed
not only for new systems orders but also for each new device design
or new device added to production test. As we increase our
installed base of FOX systems with current and new customers,
particularly with our FOX-NPTM and FOX-XP multi wafer and
singulated die/module test and burn-in systems, we expect our
consumables business will continue to grow in absolute value and as
a percentage of our total sales. Over the long term, we expect to
see a steady rate of more than 50 percent of our total annual
revenue to come from these consumables.
“We continue to receive specific forecasts from existing
customers for additional new capacity and expect additional
bookings and shipments/revenue for our systems and consumables.
These customers are in key growth segments that we have started to
penetrate including silicon photonics and silicon carbide, and
they have asked us to anticipate and secure specific capacity to
meet their needs and have indicated they expect to place orders for
this capacity this fiscal year. At the same time, COVID-19 related
impacts have affected our customers and have hindered our ability
to forecast the timing of these orders.
“Given this fiscal year’s guidance has been almost entirely
based on current customer forecasts, we are taking a more
conservative approach to our fiscal year forecast and revising our
revenue guidance for fiscal 2021 to be between $20 million and $25
million, while continuing to expect to be GAAP profitable for the
fiscal year. With a fiscal year second half revenue range of $16
million to $21 million, this new revenue range reflects
significantly increased revenue in the second half compared to
first half revenue of under $4 million.
“As we look to the second half of fiscal 2021, we remain
optimistic about the growth opportunities for our systems and
consumables within our installed base of customers, as well as our
ability to expand the number of customers using our family of
FOX-PTM solutions and have additional potential customer
engagements that could provide upside to our revenue for the fiscal
year. We maintain our confidence in the long-term demand for our
products, the attractiveness of the key markets that we serve, and
our belief that we will come out of this worldwide pandemic
stronger than we went in with more production customers, more
applications, and higher value products.”
Fiscal 2021 Financial Guidance:For the fiscal
year ending May 31, 2021, Aehr is revising its expected full year
total revenue to between $20 million and $25 million, down from
between $25 million and $28 million, and continues to expect to be
profitable for the fiscal year.
Management Conference Call and
WebcastAehr Test Systems will host a conference call and
webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its
second quarter fiscal 2021 operating results. To access the call
dial 800-437-2398 (+1 929-477-0577 outside the United States) and
give the participant pass code 4081095. In addition, a live and
archived webcast of the conference call will be available over the
Internet at www.aehr.com in the Investor Relations section. A
replay of the conference call will also be available via telephone
beginning approximately two hours after conclusion of the call
through 8:00 p.m. ET on January 14, 2021. To access the replay
dial-in information, please click here.
About Aehr Test SystemsHeadquartered in
Fremont, California, Aehr Test Systems is a worldwide provider of
test systems for burning-in and testing logic, optical and memory
integrated circuits and has installed over 2,500 systems worldwide.
Increased quality and reliability needs of the Automotive and
Mobility integrated circuit markets are driving additional test
requirements, incremental capacity needs, and new opportunities for
Aehr Test products in package, wafer level, and singulated
die/module level test. Aehr Test has developed and introduced
several innovative products, including the ABTSTM and FOX-PTM
families of test and burn-in systems and FOX WaferPakTM Aligner,
FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak
Loader. The ABTS system is used in production and qualification
testing of packaged parts for both lower power and higher power
logic devices as well as all common types of memory devices. The
FOX-XP and FOX-NP systems are full wafer contact and singulated
die/module test and burn-in systems used for burn-in and functional
test of complex devices, such as leading-edge memories, digital
signal processors, microprocessors, microcontrollers,
systems-on-a-chip, and integrated optical devices. The FOX-CP
system is a new low-cost single-wafer compact test and reliability
verification solution for logic, memory and photonic devices and
the newest addition to the FOX-P product family. The WaferPak
contactor contains a unique full wafer probe card capable of
testing wafers up to 300mm that enables IC manufacturers to perform
test and burn-in of full wafers on Aehr Test FOX systems. The
DiePak Carrier is a reusable, temporary package that enables IC
manufacturers to perform cost-effective final test and burn-in of
both bare die and modules. For more information, please visit Aehr
Test Systems’ website at www.aehr.com.
Safe Harbor StatementThis press release
contains certain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Forward-looking statements
generally relate to future events or Aehr’s future financial or
operating performance. In some cases, you can identify
forward-looking statements because they contain words such as
"may," "will," "should," "expects," "plans," "anticipates,” “going
to,” "could," "intends," "target," "projects," "contemplates,"
"believes," "estimates," "predicts," "potential," or "continue," or
the negative of these words or other similar terms or expressions
that concern Aehr’s expectations, strategy, priorities, plans, or
intentions. Forward-looking statements in this press release
include, but are not limited to, Aehr’s ability to generate
bookings and revenue increases in the future, including the second
half of fiscal 2021; future requirements and orders of Aehr’s new
and existing customers; bookings forecasted for proprietary
WaferPakTM and DiePak consumables across multiple market segments;
the temporary nature of customer pushouts; shipping timelines for
products and follow-on capacity orders; the growth of Aehr’s
systems and consumables, including as a percentage of total sales;
financial guidance for fiscal 2021, including related to revenue
and profitability; Aehr’s ability to expand its number of customers
using its FOX-PTM solutions; the ability to secure potential
customer engagements; expectations related to long-term demand for
Aehr’s productions and the attractiveness of key markets; the
belief that Aehr will be stronger after the current worldwide
COVID-19 pandemic, including expectations related to greater
production, more customers, more applications, and higher value
products. The forward-looking statements contained in this press
release are also subject to other risks and uncertainties,
including those more fully described in Aehr’s Form 10-K for fiscal
2020, Form 10-Q for the first fiscal quarter of fiscal 2021 and
other reports filed from time to time with the Securities and
Exchange Commission. Aehr disclaims any obligation to update
information contained in any forward-looking statement to reflect
events or circumstances occurring after the date of this press
release.
– Financial Tables to Follow
–
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST
SYSTEMS AND SUBSIDIARIES |
Condensed
Consolidated Statements of Operations |
(in thousands,
except per share data) |
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
Nov 30, |
|
Aug 31, |
|
Nov 30, |
|
Nov 30, |
|
Nov 30, |
|
|
|
2020 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
$ |
1,683 |
|
|
$ |
2,012 |
|
|
$ |
6,874 |
|
|
$ |
3,695 |
|
|
$ |
12,407 |
|
Cost of sales |
|
1,306 |
|
|
|
1,785 |
|
|
|
3,672 |
|
|
|
3,091 |
|
|
|
6,934 |
|
Gross profit |
|
377 |
|
|
|
227 |
|
|
|
3,202 |
|
|
|
604 |
|
|
|
5,473 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
1,501 |
|
|
|
1,514 |
|
|
|
2,157 |
|
|
|
3,015 |
|
|
|
3,965 |
|
Research and development |
|
820 |
|
|
|
900 |
|
|
|
795 |
|
|
|
1,720 |
|
|
|
1,687 |
|
Total operating expenses |
|
2,321 |
|
|
|
2,414 |
|
|
|
2,952 |
|
|
|
4,735 |
|
|
|
5,652 |
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from
operations |
|
(1,944 |
) |
|
|
(2,187 |
) |
|
|
250 |
|
|
|
(4,131 |
) |
|
|
(179 |
) |
|
|
|
|
|
|
|
|
|
|
|
Interest (expense) income, net |
|
(12 |
) |
|
|
(13 |
) |
|
|
2 |
|
|
|
(25 |
) |
|
|
14 |
|
Net gain from dissolution of Aehr Test Systems Japan |
|
- |
|
|
|
2,186 |
|
|
|
- |
|
|
|
2,186 |
|
|
|
- |
|
Other (expense) income, net |
|
(6 |
) |
|
|
(94 |
) |
|
|
5 |
|
|
|
(100 |
) |
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before
income tax (expense) benefit |
|
|
(1,962 |
) |
|
|
(108 |
) |
|
|
257 |
|
|
|
(2,070 |
) |
|
|
(150 |
) |
|
|
|
|
|
|
|
|
|
|
|
Income tax (expense) benefit |
|
(4 |
) |
|
|
215 |
|
|
|
(6 |
) |
|
|
211 |
|
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
(1,966 |
) |
|
|
107 |
|
|
|
251 |
|
|
|
(1,859 |
) |
|
|
(162 |
) |
Net (loss) income attributable to Aehr Test Systems common
shareholders |
|
$ |
(1,966 |
) |
|
$ |
107 |
|
|
$ |
251 |
|
|
$ |
(1,859 |
) |
|
$ |
(162 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per share |
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.08 |
) |
|
$ |
0.00 |
|
|
$ |
0.01 |
|
|
$ |
(0.08 |
) |
|
$ |
(0.01 |
) |
Diluted |
$ |
(0.08 |
) |
|
$ |
0.00 |
|
|
$ |
0.01 |
|
|
$ |
(0.08 |
) |
|
$ |
(0.01 |
) |
|
|
|
|
|
|
|
|
|
|
|
Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
Basic |
|
23,396 |
|
|
|
23,248 |
|
|
|
22,823 |
|
|
|
23,322 |
|
|
|
22,765 |
|
Diluted |
|
23,396 |
|
|
|
23,455 |
|
|
|
22,912 |
|
|
|
23,322 |
|
|
|
22,765 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST
SYSTEMS AND SUBSIDIARIES |
|
|
Reconciliation of GAAP and Non-GAAP Results |
|
|
(in thousands,
except per share data) |
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
|
|
|
Nov 30, |
|
Aug 31, |
|
Nov 30, |
|
Nov 30, |
|
Nov 30, |
|
|
|
|
|
|
2020 |
|
|
|
2020 |
|
|
|
2019 |
|
|
2020 |
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net (loss) income |
|
$ |
(1,966 |
) |
|
$ |
107 |
|
|
$ |
251 |
|
$ |
(1,859 |
) |
|
$ |
(162 |
) |
|
|
Stock-based compensation expense |
|
|
257 |
|
|
|
270 |
|
|
|
205 |
|
|
527 |
|
|
|
404 |
|
|
|
Income from
dissolution of Aehr Test Systems Japan |
|
|
|
- |
|
|
|
(2,401 |
) |
|
|
- |
|
|
(2,401 |
) |
|
|
- |
|
|
|
Non-GAAP net (loss) income |
|
$ |
(1,709 |
) |
|
$ |
(2,024 |
) |
|
$ |
456 |
|
$ |
(3,733 |
) |
|
$ |
242 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net (loss) income per diluted share |
|
$ |
(0.08 |
) |
|
$ |
0.00 |
|
|
$ |
0.01 |
|
$ |
(0.08 |
) |
|
$ |
(0.01 |
) |
|
|
Non-GAAP net (loss) income per diluted share |
|
$ |
(0.07 |
) |
|
$ |
(0.09 |
) |
|
$ |
0.02 |
|
$ |
(0.16 |
) |
|
$ |
0.01 |
|
|
|
Shares used in GAAP diluted shares calculation |
|
|
23,396 |
|
|
|
23,455 |
|
|
|
22,912 |
|
|
23,322 |
|
|
|
22,765 |
|
|
|
Shares used
in non-GAAP diluted shares calculation |
|
|
|
23,396 |
|
|
|
23,248 |
|
|
|
22,912 |
|
|
23,322 |
|
|
|
22,846 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net (loss)
income is a non-GAAP measure and should not be considered a
replacement for GAAP results. Non-GAAP net (loss) income is a
financial measure the Company uses to evaluate the underlying
results and operating performance of the business. The limitation
of this measure is that it excludes items that impact the Company's
current period net (loss) income. This limitation is best addressed
by using this measure in combination with net (loss) income (the
most directly comparable GAAP financial measure). These measures
are not in accordance with GAAP and may differ from non-GAAP
methods of accounting and reporting used by other companies. We
believe these measures enhance investors’ ability to review the
company’s business from the same perspective as the company’s
management and facilitate comparisons of this period’s results with
prior periods. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST
SYSTEMS AND SUBSIDIARIES |
|
Condensed
Consolidated Balance Sheets |
|
(in thousands,
except per share data) |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, |
August 31, |
|
May 31, |
|
|
|
|
|
|
2020 |
|
|
2020 |
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
3,449 |
|
$ |
6,313 |
|
$ |
5,433 |
|
|
|
Accounts receivable, net |
|
1,429 |
|
|
1,116 |
|
|
3,717 |
|
|
|
Inventories |
|
|
9,057 |
|
|
8,102 |
|
|
7,989 |
|
|
|
Prepaid expenses and other |
|
433 |
|
|
439 |
|
|
512 |
|
|
|
Total current assets |
|
14,368 |
|
|
15,970 |
|
|
17,651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
683 |
|
|
622 |
|
|
663 |
|
|
|
Operating lease right-of-use assets |
|
1,918 |
|
|
1,952 |
|
|
2,107 |
|
|
|
Other assets |
|
|
142 |
|
|
147 |
|
|
153 |
|
|
|
Total assets |
$ |
17,111 |
|
$ |
18,691 |
|
$ |
20,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable |
$ |
1,155 |
|
$ |
809 |
|
$ |
945 |
|
|
|
Accrued expenses |
|
1,344 |
|
|
1,373 |
|
|
1,439 |
|
|
|
Operating lease liabilities, short-term |
|
705 |
|
|
671 |
|
|
658 |
|
|
|
Customer deposits and deferred revenue, short-term |
|
|
|
66 |
|
|
387 |
|
|
170 |
|
|
|
Current portion of long-term debt |
|
1,213 |
|
|
933 |
|
|
653 |
|
|
|
Total current liabilities |
|
4,483 |
|
|
4,173 |
|
|
3,865 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities, long-term |
|
1,361 |
|
|
1,432 |
|
|
1,605 |
|
|
|
Long-term debt, net of current portion |
|
466 |
|
|
746 |
|
|
1,026 |
|
|
|
Deferred revenue, long-term |
|
9 |
|
|
19 |
|
|
22 |
|
|
|
Total liabilities |
|
6,319 |
|
|
6,370 |
|
|
6,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Aehr Test Systems shareholders' equity |
|
10,792 |
|
|
12,321 |
|
|
14,077 |
|
|
|
Noncontrolling interest |
|
- |
|
|
- |
|
|
(21 |
) |
|
|
Total shareholders' equity |
|
10,792 |
|
|
12,321 |
|
|
14,056 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders' equity |
$ |
17,111 |
|
$ |
18,691 |
|
$ |
20,574 |
|
|
|
|
|
|
|
|
|
|
|
|
Contacts:
Aehr Test Systems Ken
Spink
Chief Financial Officer(510) 623-9400
x309
MKR Investor Relations Inc.Todd Kehrli or Jim
ByersAnalyst/Investor Contact (323) 468-2300aehr@mkr-group.com
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Apr 2023 to Apr 2024